EMDR therapy for long-term itching
Part of Skin clinical trials.
This study tests whether a psychological therapy called EMDR (which uses eye movements to process difficult memories) can help reduce chronic itching. You may be able to join if you have had moderate to severe itching for a long time and are not on certain other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed diagnosis of chronic pruritus (long-term itching).
- Your itching has been at least a 4 out of 10 in the last week.
- You have been stable on your current treatment for at least two weeks.
- You are not currently on phototherapy (light therapy).
- You do not have serious heart disease, or a severe psychiatric condition like dementia or delusional disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry, which means it collects information about people with chronic itching. By joining, you help researchers learn more about different causes and treatments of chronic itch, with no extra tests or medicines.
This trial tests a special light treatment (photobiomodulation) to see if it can safely reduce itch. It compares the treated area to a similar untreated area on your body.
This trial tests whether combining hypnosis with virtual reality can reduce chronic itch. It may help if you have had itching for at least a year, seen a doctor for it, and it still affects your daily life despite treatment.
This trial studies whether meditation can reduce itching and improve quality of life in adults with plaque psoriasis or atopic dermatitis (eczema). It may help by calming the mind and reducing discomfort related to inflammatory skin disease.
This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
Hear when a new Chronic Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.